Digital Technology for Diabetes

Hughes, Michael S.; Addala, Ananta; Buckingham, Bruce

doi:10.1056/nejmra2215899

Cited by 59Diabetes Management and ResearchDiabetes Management and EducationMobile Health and mHealth Applications

Digital Technology for Diabetes

Open access

Hughes, Michael S., Addala, Ananta, Buckingham, Bruce·2023·New England Journal of Medicine

DOI 10.1056/nejmra2215899PMC PMC12333919

Open this paper in CoChat — free account

Abstract

Monitors to measure glucose levels have been paired with software controlling insulin delivery. The authors examine the state of the art in digital technology to manage diabetes (types 1 and 2).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra2215899

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CGM helps characterize the timing, amplitude, and frequency of excursions, and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management.
“CGM helps characterize the timing, amplitude, and frequency of excursions [133–139], and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management [140–144].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [138]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,032 · see citing works
Self-citation
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · see citing works
Self-citation
Social determinants of health and diabetes: A scientific review
Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2021) · Diabetes Care · doi:10.2337/dci20-0053 · Cited by 1,732 · see citing works
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · see citing works
Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126 · see citing works
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048 · see citing works
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030 · see citing works
Self-citation
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
TODAY Study Group (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109333 · Cited by 978 · see citing works
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684 · see citing works
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635 · see citing works
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543 · see citing works
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443 · see citing works
Self-citation
Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading
Radin, M. S. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2595-x · Cited by 361 · see citing works
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358 · see citing works
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307 · see citing works
Self-citation
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301 · see citing works
American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288 · see citing works
Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes
Brown, S. A., Forlenza, G. P., Bode, B. W., Pinsker, J. E., Levy, C. J., Criego, A. B., Hansen, D. W., Hirsch, I. B., Carlson, A. L., Bergenstal, R. M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0172 · Cited by 286 · see citing works
Self-citation
A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283 · see citing works
Self-citation
The Efficacy of Mobile Phone Apps for Lifestyle Modification in Diabetes: Systematic Review and Meta-Analysis
Wu, X., Guo, X., & Zhang, Z. (2019) · JMIR mHealth and uHealth · doi:10.2196/12297 · Cited by 249 · see citing works
Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes
Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1045-7 · Cited by 242 · see citing works
Automated insulin delivery in women with pregnancy complicated by type 1 diabetes
Lee, T. T. M., Collett, C., Bergford, S., Hartnell, S., Scott, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K., Rankin, D., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303911 · Cited by 241 · see citing works
Closed-loop insulin delivery for glycemic control in noncritical care
Bally, L., Thabit, H., Hartnell, S., Andereggen, E., Ruan, Y., Wilinska, M. E., Evans, M. L., Wertli, M. M., Coll, A. P., Stettler, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805233 · Cited by 232 · see citing works
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Carlson, A. L., Sherr, J. L., Shulman, D. I., Garg, S. K., Pop-Busui, R., Bode, B. W., Lilenquist, D. R., Brazg, R. L., Kaiserman, K. B., Kipnes, M. S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0319 · Cited by 230 · see citing works
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 226 · see citing works
Multicenter, randomized trial of a bionic pancreas in type 1 diabetes
Bionic Pancreas Research Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205225 · Cited by 216 · see citing works
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210834 · Cited by 191 · see citing works
Self-citation
HbA 1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
Lind, M., Pivodic, A., Svensson, A.-M., Ólafsdóttir, A. F., Wedel, H., & Ludvigsson, J. (2019) · BMJ · doi:10.1136/bmj.l4894 · Cited by 175 · see citing works
Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: The glucose telemetry system, a randomized clinical trial
Singh, L. G., Satyarengga, M., Marcano, I., Scott, W. H., Pinault, L. F., Feng, Z., Sorkin, J. D., Umpierrez, G. E., & Spanakis, E. K. (2020) · Diabetes Care · doi:10.2337/dc20-0840 · Cited by 154 · see citing works
Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial
Spanakis, E. K., Urrutia, A., Galindo, R. J., Vellanki, P., Migdal, A. L., Davis, G., Fayfman, M., Idrees, T., Pasquel, F. J., Coronado, W. Z., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0716 · Cited by 153 · see citing works
Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
Genuth, S., Sun, W., Cleary, P., Gao, X., Sell, D. R., Lachin, J., The DCCT/EDIC Research Group, & Monnier, V. M. (2015) · Diabetes · doi:10.2337/db14-0215 · Cited by 146 · see citing works
Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related
Akirov, A., Grossman, A., Shochat, T., & Shimon, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2653 · Cited by 127 · see citing works
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetologia · doi:10.1007/s00125-019-05034-1 · Cited by 125 · see citing works
Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative
Majidi, S., Ebekozien, O. A., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K. K., Izquierdo, R. E., Demeterco‐Berggren, C., Polsky, S., Basina, M., et al. (2021) · Clinical Diabetes · doi:10.2337/cd21-0028 · Cited by 118 · see citing works
Implicit Racial–Ethnic and Insurance-Mediated Bias to Recommending Diabetes Technology: Insights from T1D Exchange Multicenter Pediatric and Adult Diabetes Provider Cohort
Odugbesan, O., Addala, A., Nelson, G., Hopkins, R., Cossen, K., Schmitt, J. A., Indyk, J. A., Jones, N. Y., Agarwal, S., Rompicherla, S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0042 · Cited by 113 · see citing works
Self-citation
The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes
Gerhardsson, P., Schwandt, A., Witsch, M., Kordonouri, O., Svensson, J., Forsander, G., Battelino, T., Veeze, H. J., Danne, T., & on Behalf of the SWEET Study Group (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0618 · Cited by 107 · see citing works
Provider Implicit Bias Impacts Pediatric Type 1 Diabetes Technology Recommendations in the United States: Findings from The Gatekeeper Study
Addala, A., Hanes, S., Naranjo, D., Maahs, D., & Hood, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211006476 · Cited by 90 · see citing works
Self-citation
Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study
Johnson, S. R., Holmes-Walker, D. J., Chee, M., Earnest, A., & Jones, T. W. (2022) · Diabetes Care · doi:10.2337/dc21-1666 · Cited by 86 · see citing works
Uninterrupted continuous glucose monitoring access is associated with a decrease in <scp>HbA1c</scp> in youth with type 1 diabetes and public insurance
Addala, A., Maahs, D. M., Scheinker, D., Chertow, S., Leverenz, B., & Prahalad, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13082 · Cited by 83 · see citing works
Self-citation
Transitioning Insulin Pump Therapy from the Outpatient to the Inpatient Setting: A Review of 6 Years' Experience with 253 Cases
Cook, C. B., Beer, K. A., Seifert, K. M., Boyle, M. E., Mackey, P., & Castro, J. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600502 · Cited by 80 · see citing works
The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study
Bisio, A., Gonder-Frederick, L. A., McFadden, R. K., Cherñavvsky, D. R., Voelmle, M. K., Pajewski, M., Yu, P. L., Bonner, H., & Brown, S. A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820986879 · Cited by 77 · see citing works
Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy can be Safely Used in the Hospital in Select Patients
Bailon, R. M., Partlow, B. J., Miller-Cage, V., Boyle, M. E., Castro, J. C., Bourgeois, P. B., & Cook, C. B. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.24 · Cited by 65 · see citing works
M‐Health: Fundamentals and Applications
Woodward, B. (2016) · Wiley eBooks · doi:10.1002/9781119302889 · Cited by 65 · see citing works
Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis
Christensen, M. B., Gotfredsen, A., & Nørgaard, K. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2885 · Cited by 57 · see citing works
Advanced Closed-Loop Control System Improves Postprandial Glycemic Control Compared With a Hybrid Closed-Loop System Following Unannounced Meal
Garcia-Tirado, J., Diaz, J. L., Esquivel-Zuniga, R., Koravi, C. L. K., Corbett, J. P., Dawson, M., Wakeman, C., Barnett, C. L., Oliveri, M. C., Myers, H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0932 · Cited by 52 · see citing works
The financial impact of an inpatient diabetes management service
Haque, W. Z., Demidowich, A. P., Sidhaye, A., Golden, S. H., & Zilbermint, M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01374-0 · Cited by 48 · see citing works
Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes
Aktürk, H. K., Snell‐Bergeon, J. K., & Shah, V. N. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0162 · Cited by 42 · see citing works
Automated insulin delivery with remote real-time continuous glucose monitoring for hospitalized patients with diabetes: a multicenter, single-arm, feasibility trial
Davis, G. M., Hughes, M. S., Brown, S. A., Sibayan, J., Perez-Guzman, M. C., Stumpf, M., Thompson, Z., Basina, M., Patel, R. M., Hester, J., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0304 · Cited by 41 · see citing works
Self-citation
Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring
Addala, A., Ding, V. Y., Zaharieva, D. P., Bishop, F. K., Adams, A. S., King, A. C., Johari, R., Scheinker, D., Hood, K. K., Desai, M., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.8881 · Cited by 39 · see citing works
Self-citation
The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes
Scully, K. J., Palani, G., Zheng, H., Moheet, A. A., & Putman, M. S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0354 · Cited by 37 · see citing works
Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study
Bisio, A., Anderson, S. M., Norlander, L., O’Malley, G., Robic, J., OGYAADU, S. J., Hsu, L. J., Levister, C. M., Ekhlaspour, L., Lam, D. W.-H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0838 · Cited by 36 · see citing works
Self-citation
Effects of a dedicated inpatient diabetes management service on glycemic control in a community hospital setting
Demidowich, A. P., Batty, K., Love, T., Sokolinsky, S., Grubb, L., Miller, C., Raymond, L., Nazarian, J., Ahmed, M. S., Rotello, L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821993198 · Cited by 28 · see citing works
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Brazg, R., Garg, S. K., Bhargava, A., Thrasher, J. R., Latif, K., Bode, B. W., Bailey, T. S., Horowitz, B. S., Cavale, A., Kudva, Y. C., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0540 · Cited by 28 · see citing works
Self-citation
Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control Algorithm
Özaslan, B., Levy, C. J., Kudva, Y. C., Pinsker, J. E., O’Malley, G., Kaur, R. J., CASTORINO, K. N., Levister, C. M., Trinidad, M. C., Desjardins, D., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0521 · Cited by 27 · see citing works
Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review
Karol, A. B., O’Malley, G., Fallurin, R., & Levy, C. J. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.10.001 · Cited by 27 · see citing works
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections
Castle, J. R., Wilson, L. M., Tyler, N. S., ESPINOZA, A. Z., MOSQUERA-LOPEZ, C. M., Kushner, T., Young, G. M., Pinsonault, J., Dodier, R. H., Hilts, W. W., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0252 · Cited by 25 · see citing works
Efficacy of Diabetes Nurse Expert Team Program to Improve Nursing Confidence and Expertise in Caring for Hospitalized Patients With Diabetes Mellitus
Corl, D. E., McCliment, S., Thompson, R., Suhr, L. D., & Wisse, B. E. (2014) · Journal for Nurses in Professional Development · doi:10.1097/nnd.0000000000000068 · Cited by 25 · see citing works
Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve
Beck, R. W., & Bergenstal, R. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0090 · Cited by 21 · see citing works

Flagged first, then by citations

Research works printed but not linked: 1

[16]ElSayed NA, Aleppo G, Aroda VR, Diabetes technology: standards of care in diabetes-2023. Diabetes Care 2023; 46: Suppl: S111– S127. 36507635 PMC9810474

Sorted by citations

Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Ginsburg, G. S., Picard, R. W., & Friend, S. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2307160 · Cited by 138 · see citing works
Wearable Digital Health Technology
Friend, S. H., Ginsburg, G. S., & Picard, R. W. (2023) · New England Journal of Medicine · doi:10.1056/nejme2303219 · Cited by 68 · see citing works
Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes
Fang, M., Xu, Y., Ballew, S. H., Coresh, J., Echouffo-Tcheugui, J. B., Selvin, E., & Shin, J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.26353 · Cited by 44 · see citing works
Digital health: current applications, challenges, and future directions for enhancing healthcare quality and safety
Hu, S., Song, D., Wan, S., Zhang, S., Luo, C., Li, N., Liu, G., Vasconcelos, J. D. G. E. S., de Carvalho, L. L. C., Neobísi, E., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1646802 · Cited by 82 · see citing works
“Remote blood glucose monitoring combined with AI algorithms, generates virtual models of diabetes to optimize insulin dosage and lifestyle guidance (60), enabling patients to maintain a high quality of life while alleviating the burden on the healthcare system (61).”
Dual ROS/Glucose-Responsive Quercetin-Loaded Supramolecular Hydrogel for Diabetic Wound Healing
Liu, H., Ai, R., Liu, B., & He, L. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c01331 · Cited by 28 · see citing works
Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies
Suresh, M. G., Mohamed, S., Geetha, H. S., Prabhu, S., Trivedi, N., Ng, Z. C., Mehta, P. D., Brar, A. S., Sohal, A., Goyal, M. K., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.113149 · Cited by 30 · see citing works
A case study on using a large language model to analyze continuous glucose monitoring data
Healey, E., Tan, A. L. M., Flint, K. L., Ruiz, J., & Kohane, I. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-84003-0 · Cited by 28 · see citing works
State of the art of mobile health technologies use in clinical arrhythmia care
Sridhar, A. R. M., Cheung, J. W., Lampert, R., Silva, J. N. A., Gopinathannair, R., Sotomonte, J. C., Tarakji, K. G., Fellman, M., Chrispin, J., Varma, N., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00618-4 · Cited by 28 · see citing works
“A full discussion of the transformative roles of mHealth and digital health technologies in diabetes management is beyond the scope of this article, but a comprehensive review on the subject has recently been published 100 .”
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Dyńka, D., Rodzeń, Ł., Rodzeń, M., Łojko, D., Kraszewski, S., Ibrahim, A., Hussey, M., Deptuła, A., Grzywacz, Ż., Ternianov, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164857 · Cited by 23 · see citing works
“The possible tools may include the continuous glucose monitoring (CGM) technology, which is the use of glucose sensors that show current blood glucose concentration without the need for constant finger-pricking, making it easier to stabilize glucose and ultimately reduce HbA1c levels [184].”
Background
Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial
Laesser, C. I., Piazza, C. D., Schorno, N., Nick, F., Kastrati, L., Züger, T., Barnard-Kelly, K. D., Wilinska, M. E., Nakas, C. T., Hovorka, R., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06319-w · Cited by 19 · see citing works
Technological functionality and system architecture of mobile health interventions for diabetes management: a systematic review and meta-analysis of randomized controlled trials
Yu, X., Wang, Y., Liu, Z., & Jung, E. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1549568 · Cited by 26 · see citing works
“Technological advancements, particularly the emergence of mobile health applications (Apps), have significantly influenced the landscape of diabetes care in recent years (7, 8).”
Cumulative Burden of Digital Health Technologies for Patients With Multimorbidity
Phi, N. T. T., Montori, V. M., Kunneman, M., Ravaud, P., & Tran, V.-T. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.7288 · Cited by 19 · see citing works
The Future of Telemedicine for Obstructive Sleep Apnea Treatment: A Narrative Review
Bailly, S., Mendelson, M., Baillieul, S., Tamisier, R., & Pépin, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092700 · Cited by 18 · see citing works
The future is here: an overview of technology in diabetes
Mallik, R., Kar, P. S., Mulder, H., & Krook, A. (2024) · Diabetologia · doi:10.1007/s00125-024-06235-z · Cited by 16 · see citing works
Carbohydrate Estimation Accuracy of Two Commercially Available Smartphone Applications vs Estimation by Individuals With Type 1 Diabetes: A Comparative Study
Baumgartner, M., Kuhn, C., Nakas, C. T., Herzig, D., & Bally, L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241264744 · Cited by 10 · see citing works
Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications: A Randomized Clinical Trial
Pantalone, K. M., Xiao, H., Bena, J., Morrison, S. M., Downie, S., Boyd, A., Shah, L., Willis, B., Beharry-Diaz, J., Milinovich, A., et al. (2025) · NEJM Catalyst · doi:10.1056/cat.25.0016 · Cited by 11 · see citing works
Digital Health for Asthma Management: Electronic Medication Monitoring for Adherence as a Case Example
Keyser, H. H. D., Anderson, W. C., Stempel, D. A., & Szefler, S. J. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.12.042 · Cited by 9 · see citing works
The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy
Tumminia, A., Santoro, G. M., Oteri, V., Galeano, F., Baratta, R., Gullo, D., Frittitta, L., Sciacca, L., Moli, R. L., Piticchio, T., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112173 · Cited by 9 · see citing works
Patient-centric care: Unveiling the potential of wearable electronics in clinical practice
Zhao, P., Xu, J., & Han, M. (2024) · Wearable electronics. · doi:10.1016/j.wees.2024.07.001 · Cited by 9 · see citing works
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations
Lippi, G., Pighi, L., & Mattiuzzi, C. (2024) · Diagnostics · doi:10.3390/diagnostics14182037 · Cited by 8 · see citing works
“The type of device abilities, and/or blood lifestyle or insulin in real time [20].”
BackgroundInfluential
Teplizumab for stage 2 type 1 diabetes: a new era in pediatric diabetes prevention
Zaitoon, D., & Zaitoon, H. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06520-y · Cited by 7 · see citing works
“Moreover, effective use requires education and ongoing sup-port—resources that are not uniformly accessible across populations [30, 31].”
Digital Solutions for the Optimization of Pharmacologic Therapy for Heart Failure
DeVore, A. D., Walsh, M. N., Vardeny, O., Albert, N. M., & Desai, A. S. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.10.014 · Cited by 7 · see citing works
Efficacy of Nurse‐Led Digitalized Diabetes Management Program for Community‐Dwelling Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Makhfudli, M., Efendi, F., Pradipta, R. O., Ismanto, A. Y., Chong, M. L., & Tonapa, S. I. (2025) · Journal of Nursing Scholarship · doi:10.1111/jnu.70022 · Cited by 6 · see citing works
Integrating Consumer-Grade Wearable Devices and Patient-Generated Health Data into Clinical Care: Perspectives from Healthcare Professionals at a Learning Health System
Mak, S., Kinney, R. L., Bailey, A. L., Gaffey, A. E., Relyea, M., Spanakis, E. K., & Ash, G. I. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09876-x · Cited by 6 · see citing works
Digital Technology for Diabetes
Kinny-Köster, B., Michalski, C. W., & Loos, M. (2024) · New England Journal of Medicine · doi:10.1056/nejmc2315000 · Cited by 6 · see citing works
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors
Hughes, M. S., Aleppo, G., Bally, L., Batista, A. F. M. B., Brown, S. A., Faulds, E. R., Gonder-Frederick, L. A., Isaacs, D. M., Kahkoska, A. R., Ortega, J., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241296853 · Cited by 6 · see citing works
Self-citation
Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies
Romón, Í., González-Barrera, S., de Portugal, C. C., Ocio, E. M., & Sampedro, I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1366962 · Cited by 5 · see citing works
The current status and influencing factors of diabetes knowledge among non-endocrinology nurses of tertiary general hospitals: a cross-sectional survey study
Song, J., Su, L., Gu, C., Zhao, S., Li, X., Liu, S., Tuo, J., & Huang, S. (2025) · BMC Nursing · doi:10.1186/s12912-025-02741-6 · Cited by 4 · see citing works
“This may be attributed to the continuous advancements in diabetes prevention and treatment technologies, the rapid updates and iterations of medications, the complexity of drug mechanisms, and the variability in treat-ment plans [30].”
Trust in Medical AI: The Case of mHealth Diabetes Apps
Materne, S., Canali, S., & Chiffi, D. (2025) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70216 · Cited by 4 · see citing works
“We will focus in particular on the context of mHealth apps for the treatment of diabetes, a chronic condition (chronic disease management is one of the most dominant areas for mHealth app usage), where patient trust is a crucial element [17].”
What are end-users’ needs and preferences for a comprehensive e-health program for type 2 diabetes? – A qualitative user preference study
Rishaug, T., Aas, A., Henriksen, A., Hartvigsen, G., Birkeland, K. I., & Årsand, E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318876 · Cited by 4 · see citing works
“Use of glucose sensors (CGMs) in patients with T2D can give greater improvements in glycaemic outcomes compared to standard fingerstick monitoring [41].”
The transformative role of artificial intelligence in diabetes care and research
Canha, D., Bour, C., Barraud, S., Aguayo, G., & Fagherazzi, G. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101565 · Cited by 4 · see citing works
Big Data, Machine Learning, and Personalization in Health Systems: Ethical Issues and Emerging Trade-Offs
Canali, S., Falcetta, A., Pavan, M., Roveri, M., & Schiaffonati, V. (2025) · Science and Engineering Ethics · doi:10.1007/s11948-025-00552-1 · Cited by 3 · see citing works
“In a recent series published in the leading medical journal New England Journal of Medicine (Friend et al., 2023 ), one of the first published articles was dedicated to CGMs, presenting these devices as one of the most common types of wearable and digital health technologies (Hughes et al., 2023).”
Management of Continuous Glucose Monitors in Radiation Oncology Patients
Zeng, J., Kosak, T. K., Malkani, S., Hudson, J., Martin, N. E., Tishler, R. B., & Pashtan, I. M. (2024) · Practical Radiation Oncology · doi:10.1016/j.prro.2024.06.016 · Cited by 2 · see citing works
Digital technologies for climate-related health education, behavior and risk reduction: a systematic scoping review
Morris, N. B., Barnes, M., Rybarczyk, A., & Chaseling, G. K. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01907-5 · Cited by 2 · see citing works
EndoCompass project: research roadmap for diabetes, obesity, and metabolism
Mathieu, C., Meireles, M., Pagotto, U., Wabitsch, M., Banerjee, I., Bartolomé, A., Battelino, T., Beck, J., Chiarelli, F., León, D. D. D., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf065 · Cited by 4 · see citing works
Diabetes treatment by conversion of gut epithelial cells to insulin‐producing cells
Accili, D., Talchai, S. C., Bouchi, R., Lee, A. Y., Du, W. J., Kitamoto, T., McKimpson, W. M., Belvedere, S., & Lin, H. V. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14175 · Cited by 2 · see citing works
Text messaging to enhance glucose monitoring and self-care in teens with type 1 diabetes: Teens’ perceptions predict outcomes
Chen, C. W., Serata, E., Scheub, R., Dassau, T., Wasserman, R. M., Anderson, B. J., Volkening, L. K., & Laffel, L. M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111719 · Cited by 2 · see citing works
Study protocol for a non-inferiority, multicenter, randomized study to evaluate a smartphone app-based follow-up program after bariatric surgery (BELLA plus trial)
Ueter, S., Taebi, N., Weiß, C., Hetjens, M., Reißfelder, C., Blank, S., Otto, M., & Yang, C. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107615 · Cited by 2 · see citing works
Out of Sight, Out of Mind: A Call to Action for the Treatment of Hypoglycemia
Goldman, J. D., & Isaacs, D. M. (2024) · Clinical Diabetes · doi:10.2337/cd24-0014 · Cited by 1 · see citing works
Cause-Specific Death in Adults with Type 1 Diabetes and Type 2 Diabetes: Insights from the UK Biobank
Ostrominski, J., Cho, S. M. J., Vaduganathan, M., & Honigberg, M. C. (2024) · Diabetes, obesity and metabolism · doi:10.1111/dom.16009 · Cited by 2 · see citing works
“Digital technologies, such as wearable automated insulin delivery systems, 24 may additionally enhance glycaemic control, which remains a leading modifiable driver of morbidity among older adults with T1D.”
Establishment of a Diabetes-Tailored Data Intelligence Platform Enhances Clinical Care, Enables Risk-Based Monitoring, and Facilitates Population-Health-Based Approaches at a Pediatric Diabetes Network
Lockee, B., Vandervelden, C. A., Tilden, D. R., Panfil, K., Tallon, E. M., DeWit, E., Noland, K., Williams, D. D., Gill, H. S., Patton, S. R., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251367776 · Cited by 2 · see citing works
“11 22-24 The 2022 iCoDE Report: CGM-EHR Integration Standards and Recommendations summarizes these benefits and provides technical and operational guidance to facilitate the process.”
Evidence-based medicine and the promises and limits of digital health and wearable technology
Canali, S., Schiaffonati, V., & Aliverti, A. (2026) · Studies in History and Philosophy of Science Part A · doi:10.1016/j.shpsa.2025.102097 · Cited by 1 · see citing works
Optimising care for uncomplicated type 2 diabetes mellitus in Lagos, Nigeria: cost and benefit estimates using real-world data
Ifeanyichi, M., Gómez-Pérez, G. P., Banigbe, B., Dada, I., Dada, A. A., Zamba, E., van Andel, J. M., de Wit, T. F. R., & Dieteren, C. (2026) · BMJ Global Health · doi:10.1136/bmjgh-2025-019477 · Cited by 1 · see citing works
“However, its applicability is substantially limited by differences in the study population biology, lifestyles, socioeconomic profiles and broader healthcare system designs.”
Biofuel Cell‐Based Potentiostat‐Free Smart Diaper Sensor for Urinary Glucose Monitoring
Mwaurah, M. M., Anuja, A. P., Nakagawa, T., Mathiyarasu, J., & Mohan, A. M. V. (2025) · Analysis & Sensing · doi:10.1002/anse.202500039 · Cited by 1 · see citing works
Simplified Meal Announcement Study (SMASH) Using Hybrid Closed-Loop Insulin Delivery in Youth and Young Adults with Type 1 Diabetes – A Randomised Controlled Two-Centre Crossover TrialPreprint
Laesser, C. I., Piazza, C. D., Schorno, N., Nick, F., Kastrati, L., Züger, T., Barnard, K. D., Wilinska, M. E., Nakas, C. T., Hovorka, R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4774472 · Cited by 1 · see citing works
Diabetic gastroparesis: pathophysiology and impact on insulin timing choices
Galeano, F., Tumminia, A., Oteri, V., Le Moli, R., Piticchio, T., Scilletta, S., Di Marco, M., Di Pino, A., & Frasca, F. (2026) · Endocrine · doi:10.1007/s12020-026-04693-6
“Provides metrics such as time in range, time in hypoglycemia, and glycemic variability, which are essential for dynamic insulin adjustment in gastroparesis [133, 135–138].”
Flash glucose monitoring in diabetes
Lameijer, A. (2024) · doi:10.33612/diss.1021051970
Collaborative Governance Empowered by Digital Technology - Construction of Precision Intelligent Control and Early Warning Platform for Construction Solid Waste
You, Y., Chew, B. C., & Fan, H. (2024) · Procedia Computer Science · doi:10.1016/j.procs.2024.10.087
Technological functionality and system architecture of mobile health interventions for diabetes management: A systematic review and meta-analysis of randomized controlled trials (Preprint)Preprint
Yu, X., Wang, Y., & Liu, Z. (2024) · doi:10.2196/preprints.70164
EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism
Mathieu, C., Meireles, M., Pagotto, U., Wabitsch, M., Banerjee, I., Bartolomé, A., Battelino, T., Beck, J., Chiarelli, F., León, D. D. D., et al. (2025) · Hormone Research in Paediatrics · doi:10.1159/000549194
“Finally, CGM is a core component of glucose-responsive automated insulin delivery (AID) systems [167].”
Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study
Nagaraj, S., Rabinowicz, R., Goodday, S., Brunga, L., Korenblum, C., Villani, A., Kim, R. H., Karlin, E., Greer, R. W., Balaci, H., et al. (2026) · JMIR Formative Research · doi:10.2196/74375
Continuous glucose monitoring in paediatric residents with normal glucose metabolism: correlations to 24-hour duty schedule
Sotiriou, G., Proimou, A., Panagopoulou, P., Tsimtsiou, Z., & Christoforidis, A. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01871-1
“In recent years, the use of continuous glucose monitoring (CGM) systems has significantly improved glycemic control of people with type 1 diabetes mellitus, and has also helped to acquire valuable data on glucose metab - olism in other diseases and in healthy populations [7].”
Barriers to the Adoption of Diabetes Technologies and the Implementation of Connected Insulin Pens in a Largely Minority Population With Type 1 Diabetes
Bello, M. A. Y., Pesantez, M. J., Saalinger, M. N., Sanz, A. M., Shikh, S., Mesa, B., Chirinos, A. A., Macias, A. J., Nisenboym, T., Bernal‐Mizrachi, E., et al. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0072
“These technologies have been associated with lower hemoglobin A 1c (A1C) levels, increased time in range, and reduced hypoglycemia (2–6, 10 ).”
Cetoacidosis diabética asociada a la reutilización de material de un solo uso en paciente con diabetes mellitus tipo1 tratada con sistema de asa cerrada híbrida avanzada: a propósito de un caso
Calles, A. L., Chaparro, P. P., & Fernández, J. M. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501820
Transforming Medical Devices Through Software Innovation
Needham, C., Lechner, J., Stojanovski, K., صالح, ز., & Mohd, T. K. (2026) · IEEE International Conference on Secure IoT, Assured and Trusted Computing (SATC) · doi:10.1109/satc69565.2026.11542357
“Hughes et al. [17] explore digital technology in the context of diabetes management.”
Microneedle technology for diabetes therapy
Wang, W., & Wu, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45544-5.00009-9
Vers une diabétologie augmentée par l’IA : état des lieux et perspectives
Fagherazzi, G. (2026) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(25)48886-6
The Role of Diabetes Technology in Primary Care
Martens, T. W. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.09.001
Capturing human-machine interplay in automated insulin delivery systems through day-to-day variability of the automated correction index (ACI-V%)
Tumminia, A., Papa, G., Cannarella, R., Galeano, F., Oteri, V., Amato, V., Baratta, R., Condorelli, R. A., Palazzolo, R., Gusmano, C., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113613

Authors: Hughes, M. S., Addala, A., & Buckingham, B.
Affiliations: Stanford Medicine (US)
ORCID: Hughes, Michael S.
Addala, Ananta
Buckingham, Bruce
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2023-11-30
Volume: 389
Issue: 22
Pages: 2076-2086
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra2215899
PMC: PMC12333919
OpenAlex: W4389120388
Cited by: 59
References: 59
Citations by year: 2026: 13 · 2025: 22 · 2024: 23 · 2023: 1
FWCI: 2.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (K12DK122550, P30DK116074, K23DK131342)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords: diabetes management, digital health technologies, glucose monitoring, continuous glucose monitoring, insulin delivery, insulin pump, artificial pancreas, type 1 diabetes, type 2 diabetes
MeSH terms: Digital Technology, Diabetes Mellitus, Humans, Technology, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Digital Technology for Diabetes

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks